Forever Chemicals, Real Impacts: Insights from ISPE Boston’s PFAS Session

Posted by Howard Sneider
On May 19, 2025

The ISPE Boston Area Chapter was happy to host last month’s event: “PFAS: Understanding ‘Forever Chemicals’ and their potential impacts on pharmaceutical manufacturing”. The event was very informative, and the question-and-answer session postponed the end time by 45 minutes. Our speakers provided an informative session and left everyone in attendance with a greater understanding of […]

Bedford Site to be Redeveloped for Biomanufacturing

Posted by ISPE Boston
On May 8, 2025

Bain Capital Real Estate is teaming with Botanic Properties, a real estate investment and development firm focused on the biomanufacturing industry, to acquire 45 Crosby Drive in Bedford. The investment is being made by GenesisM, a specialized real estate platform dedicated to developing purpose-built biomanufacturing facilities. Financial terms of the purchase were not disclosed. The […]

Welcome New Members April 2025

Posted by ISPE Boston
On May 5, 2025

We would like to introduce the Members who joined ISPE in April 2025, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

New Podcast Episode: Behind Pharma’s Reputation with Ray Jordan

Posted by ISPE Boston
On May 1, 2025

In the latest episode of the Future of Pharma, host Samir Gondalia, is joined by a true heavyweight in corporate affairs and reputation strategy—Ray Jordan, Principal at Putnam Insights. Ray’s career spans some of the most influential companies in healthcare and biotech, including Moderna, Amgen, Johnson & Johnson, and Pfizer. With decades of experience helping […]

Verve’s Cholesterol-Lowering Treatment Shows No Safety Issues in Trial

Posted by ISPE Boston
On May 1, 2025

Verve Therapeutics has won FDA clearance of its Investigational New Drug (IND) application for VERVE-102 for the treatment of patients with familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD). VERVE-102 is a novel, investigational in vivo base editing medicine designed to be a single-course treatment that inactivates the PCSK9 gene in the liver to durably lower blood low-density […]

Student Voices: Reflections on the 2025 ISPE Aseptic Conference

Posted by Ashutosh Anand
On April 24, 2025

The 2025 ISPE Aseptic Conference held March 17-18 in Washington, D.C., brought together professionals and students from across the pharmaceutical and biotech sectors to share insights, innovations, and challenges in aseptic manufacturing. Through the generous ISPE Student Grant program, three Northeastern University students—Afrah Mujeeb (MS Regulatory Affairs), Savani Nagarkar (MS Biotechnology), and Nazneen Khan (MS […]

Behind the Counter: What You Don’t See About Drug Prices – Featuring Vinay Patel on the Future of Pharma Podcast

Posted by ISPE Boston
On April 17, 2025

The ISPE Boston Area Chapter’s Future of Pharma Podcast continues to explore the cutting edge of life sciences and healthcare with conversations that push beyond the lab and into the systems that support patients every day. In Episode 32, we take a detour from the usual lineup of pharmaceutical industry leaders and turn our attention […]

Sionna Therapeutics Goes Public with $219 Million IPO

Posted by ISPE Boston
On April 10, 2025

Sionna Therapeutics, a Waltham biotech targeting cystic fibrosis, has closed its IPO, raising about $219 million. Sionna is a clinical-stage company seeking to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Sionna’s goal is to deliver differentiated medicines for […]

Chapter Member Anniversaries: April 2025

Posted by ISPE Boston
On April 4, 2025

Please congratulate the following members celebrating milestone anniversaries in April 2025. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Ryan Ark, Alnylam Pharmaceuticals Robert P. Barreira Rick E. Cavalli, Stellix Global Services Michael S. Cheney, Biogen Idec Donald Cole, Hart Passivation Services, Inc. Gregg A. Conboy, Erland […]

Welcome New Members March 2025

Posted by ISPE Boston
On April 4, 2025

We would like to introduce the Members who joined ISPE in March 2025, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Page 1 of 11712 3 ›»